MARKET MELTDOWN: How Novo Nordisk Lost Its Crown in the $100 Billion GLP-1 Race
The pharmaceutical giant that once seemed unstoppable has stumbled. Novo Nordisk, until recently Europe's most valuable listed company and the undisputed leader in the booming weight loss drug market, is facing a reckoning that has sent shockwaves through global markets and raised questions about the future of the